Meglumine Metrizoate

Meglumine Metrizoate (Methylglucamine metrizoate) is an ionic water-soluble contrast medium. Meglumine Metrizoate has a good imaging effect in cerebral angiography. Compared with the non-ionic contrast medium Metrizamide (HY-W000133), Meglumine Metrizoate has a higher probability of causing adverse effects such as EEG deterioration and bradycardia[1].

Product Specifications

CAS Number

[7241-11-4]

Product Name Alternative

Methylglucamine metrizoate

UNSPSC

12352005

Hazard Statement

H317

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Neurological Disease; Cardiovascular Disease

Smiles

O=C(O)C1=C(I)C(N(C(C)=O)C)=C(I)C(NC(C)=O)=C1I.O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)CNC

Molecular Formula

C19H28I3N3O9

Molecular Weight

823.15

Precautions

P261-P272-P280-P302+P352-P362+P364-P501

References & Citations

[1]Skalpe IO, et al. Cerebral angiography with non-ionic (metrizamide) and ionic (meglumine metrizoate) watersoluble contrast media. A comparative study with double blind technic. Neuroradiology. 1977 Aug 25;14 (1) :15-9.